Printer Friendly
The Free Library
19,595,260 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AstraZeneca Merger Closing Timetable and Revised Dividend Payment Dates.


WILMINGTON, Del.--(BUSINESS WIRE)--March 25, 1999--ZENECA GROUP PLC and ASTRA AB Astra AB is a former international pharmaceutical company based in Södertälje, Sweden. Astra was formed in 1913 and merged with the British Zeneca Group in 1999 to form AstraZeneca.  announce that, as a result of the US anti-trust approval announced earlier today, they are able to provide further details of certain aspects of the closing timetable for the proposed merger.

The US anti-trust approval fulfils the only remaining regulatory consent required to effect the proposed merger.

CLOSING TIMETABLE

As announced on 16 March 1999, the initial acceptance period for the Merger Offers made by Zeneca for all the issued share capital of Astra AB will close on Tuesday 30th March 1999 at 3.00 p.m. (Stockholm time) (9.00am New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 time). An announcement as to the level of acceptances of the Merger Offers will be made on or shortly after Tuesday 6 April 1999.

If an announcement declaring the Merger Offers wholly unconditional can be made by 7.30 am (UK time) on 6 April 1999, it is anticipated that the following arrangements in the respective Stock Exchanges will apply:

-- London Stock Exchange London Stock Exchange

London marketplace for securities. It was formed in 1773 by a group of stockbrokers who had been doing business informally in local coffeehouses.
 listing will be granted and dealings will

commence in the new AstraZeneca shares at 9.00 am (UK time) on 6

April 1999.

Subject to the new AstraZeneca shares being listed at 7.30 am on

6 April 1999, it is anticipated that AstraZeneca will replace

Zeneca in the FTSE FTSE

A company that specializes in index calculation. Although not part of a stock exchange, co-owners include the London Stock Exchange and the Financial Times.

Notes:
The FTSE is similar to Standard & Poor's in the United States.
 100 and All-Share indices from 9.00 am (UK

time) on 6 April 1999. Full details will be the subject of a

separate announcement by the FTSE Equity Indices Committee and

FT/S&P World Index Policy Committee.

-- Stockholm Stock Exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries.  listing will be granted and dealings

will commence in the new AstraZeneca shares at 10.00 am

(Stockholm time) on 6 April 1999.

Subject to the new AstraZeneca shares being listed on 6 April

1999, AstraZeneca will replace Astra ASTRA Ancient Instruments Sound/Timbre Reconstruction Application
ASTRA Australian Strategic Air Traffic Management Group
ASTRA Arab Supply and Trading Corporation
ASTRA Automatic System for Transport Analysis
ASTRA Automatic Satellite Tracking Research Antenna
 in the Aff,rsv,rldens

Generalindex, the SX General, the SX 16, SX Chemicals and

Pharmaceuticals, the OMX OMX Office Max (stock symbol)  and the OMSX indices from 10.00 am

(Stockholm time) on 7 April 1999. New York Stock Exchange New York Stock Exchange (NYSE)

World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City.
 

dealings in the new AstraZeneca Depository shares will commence

at 9.30 am (New York time) on 6 April 1999. The symbol for

AstraZeneca will be 'AZN' on all three exchanges.

DIVIDEND PAYMENT DATE

To ensure equal treatment of shareholders in Zeneca and Astra, the Boards of Zeneca and Astra have agreed to establish a common payment date for dividends in Astra and Zeneca (or AstraZeneca, assuming the merger is declared wholly unconditional before 9 April 1999) of Wednesday 21 April 1999.

This date replaces the previously announced Zeneca dividend payment date of 26 April 1999 and the anticipated Astra dividend despatch date by VPC (1) (Virtual Processor Complex) An IBM mainframe multiprocessing system that uses several computers under tight central control.

(2) See Virtual PC.
 AB of 16 April 1999.

If the Merger Offers are declared wholly unconditional before 9 April 1999, holders of AstraZeneca American Depository Shares (including holders of Astra American Depository Shares who have accepted the US offer) will receive the AstraZeneca dividend through Morgan Guaranty on or about 28 April 1999. The common record date for dividends in both Zeneca and Astra will remain as 9 April 1999.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:4EUSW
Date:Mar 25, 1999
Words:506
Previous Article:FineLine Has Caught THE KOOTIES!
Next Article:Advanced Systems International Awarded Microsoft Certified Solution Provider.
Topics:



Related Articles
FT/S&P Actuaries World Index - Further re Astra / Zeneca Merger.
J.P. Morgan announces AstraZeneca ADR trading.
AstraZeneca Agrees to Vote Its SUGEN Shares in Support of Pharmacia & Upjohn Merger Proposal.
AstraZeneca PLC Announces Half Year Results 1999.
IMS HEALTH Strategic Technologies Signs AstraZeneca Operations in Italy for its Pharbase and Premiere Pharmaceutical Relationship Management...
Launch of a Global Leader in Agribusiness - Novartis to Focus on Healthcare: Novartis and AstraZeneca Announce Spin-Off Followed by Merger of...
DENTSPLY International Announces Agreement for Acquisition of AstraZeneca's Oraqix Product; and Fourth Quarter Expectations.
Dyax Announces Collaboration With AstraZeneca On Antibody Discovery and Optimization.
Abgenix and AstraZeneca Successfully Close Equity Transaction for New Oncology Alliance.
Gerald McDole, Former CEO of AstraZeneca, Appointed to Medicure Board of Directors.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles